Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | PTPRA | P18433 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.41 |
| ▸ | ALKBH2 | Q6NS38 | 1/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
| ▸ | ALKBH3 | Q96Q83 | 1/20 | 0.41 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16058321 | 0.80 | ADAMTS5 (0.52) | MEN1KMT2APTPRAADAMTS5HSD17B10 | |
| SCHEMBL21885547 | 0.80 | ADAMTS5 (0.52) | MEN1KMT2APTPRAADAMTS5HSD17B10 | |
| SCHEMBL32668282 | 0.79 | MEN1 (0.54) | MEN1KMT2ANPSR1 | |
| Bromide SCHEMBL29831731 | 0.79 | ADAMTS5 (0.51) | MEN1KMT2APTPRAADAMTS5HSD17B10 | |
| SCHEMBL5693309 | 0.73 | KMT2A (0.54) | MEN1KMT2ANPSR1 | |
| SCHEMBL29182363 | 0.72 | MEN1 (0.46) | MEN1KMT2ANPSR1 | |
| SCHEMBL25227152 | 0.72 | KMT2A (0.56) | MEN1KMT2ANPSR1 | |
| SCHEMBL25277181 | 0.72 | KMT2A (0.56) | MEN1KMT2ANPSR1 | |
| SCHEMBL21837591 | 0.72 | MEN1 (0.46) | MEN1KMT2ANPSR1 | |
| SCHEMBL21837408 | 0.72 | MEN1 (0.46) | MEN1KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107709301-B | Pyrazole derivative or pharmacologically acceptable salt thereof | 橘生药品工业株式会社 | 2021-06-22 | — | — | CN | disclosed |